... San Antonio Breast Cancer Symposium (SABCS 2025) being held December 9 ... Biotechnology. NiKang Therapeutics Inc. Logo. NiKang Therapeutics ...
News
- NiKang Therapeutics Presents Discovery of NKT5097, a First-in-Class, Highly Potent and ...
- Intensity Therapeutics, Inc. to Present Two Posters at the 2025 - GuruFocus
... Biotechnology NAS:INTS. Intensity Therapeutics, Inc. to Present Two Posters at the 2025 San Antonio Breast Cancer Symposium. Author's Avatar.
- NiKang Therapeutics Presents Discovery of NKT5097, a First-in-Class, Highly ... - Rutland Herald
... San Antonio Breast Cancer Symposium (SABCS 2025) being held December 9 ... NiKang Therapeutics is a clinical-stage biotech company focused on ...
- ADC Post-Endocrine Therapy Misses Mark in Advanced Breast Cancer Trial
SAN ANTONIO -- The antibody-drug conjugate (ADC) sacituzumab govitecan ... Biotechnology. Lathrop had no relevant financial disclosures ...
- Wobble Genomics To Present New Data At SABCS Confirming Platform's Ability To ... - Morningstar
EDINBURGH, Scotland, Dec. 11, 2025 /PRNewswire/ -- Wobble Genomics, a biotechnology ... San Antonio, Texas. The data demonstrates the ability to ...